Cargando…
TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP
BACKGROUND: Currently, how to successfully control refractory and metastatic diseases remains a fundamental goal for clinicians to improve therapeutic effects for patients with non-small cell lung cancer (NSCLC). Several studies have discovered that TRIM58, a member of tripartite motif protein famil...
Autores principales: | Shang, Rongxin, Chen, Jiakuan, Gao, Yang, Chen, Jijun, Han, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836804/ https://www.ncbi.nlm.nih.gov/pubmed/36644609 http://dx.doi.org/10.1155/2023/5899662 |
Ejemplares similares
-
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway
por: Lin, Zhaoxian, et al.
Publicado: (2023) -
miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
por: GUO, FEI, et al.
Publicado: (2014) -
ZEB1 in Pancreatic Cancer
por: Wellner, Ulrich, et al.
Publicado: (2010) -
The Curious Case of ZEB1
por: Madany, Mecca, et al.
Publicado: (2018) -
Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
por: Su, Wenjing, et al.
Publicado: (2017)